{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:56:29Z","timestamp":1788173789009,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12013-024-01226-8","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T18:02:16Z","timestamp":1707415336000},"page":"767-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Berberine ameliorates the progression of primary sclerosing cholangitis by activating farnesoid X receptor"],"prefix":"10.1007","volume":"82","author":[{"given":"Hassan","family":"Hameed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nida","family":"Irshad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Abrar","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Mumtaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imran","family":"Sohail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"1226_CR1","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","volume":"60","author":"P Fickert","year":"2014","unstructured":"Fickert, P., Pollheimer, M. J., Beuers, U., Lackner, C., Hirschfield, G., Housset, C., Keitel, V., Schramm, C., Marschall, H. U., Karlsen, T. H., Melum, E., Kaser, A., Eksteen, B., Strazzabosco, M., Manns, M., & Trauner, M. (2014). Characterization of animal models for primary sclerosing cholangitis (PSC). Journal of Hepatology, 60, 1290\u20131303.","journal-title":"Journal of Hepatology"},{"key":"1226_CR2","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1053\/j.gastro.2013.06.052","volume":"145","author":"JE Eaton","year":"2013","unstructured":"Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013). Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management. Gastroenterology, 145, 521\u2013536.","journal-title":"Gastroenterology"},{"key":"1226_CR3","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor, K. D., Kowdley, K. V., Luketic, V. A., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Mooney, J., Sargeant, C., Braaten, J., Bernard, T., King, D., Miceli, E., Schmoll, J., Hoskin, T., Thapa, P., & Enders, F. (2009). High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology, 50, 808\u2013814.","journal-title":"Hepatology"},{"key":"1226_CR4","first-page":"Cd004036","volume":"2010","author":"V Giljaca","year":"2010","unstructured":"Giljaca, V., Poropat, G., Stimac, D., & Gluud, C. (2010). Glucocorticosteroids for primary sclerosing cholangitis. The Cochrane Database of Systematic Reviews, 2010, Cd004036.","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"1226_CR5","first-page":"589","volume":"36","author":"I Mousavere","year":"2023","unstructured":"Mousavere, I., Kalampokis, G., Fousekis, F., Karayiannis, P., Baltayiannis, G., & Christodoulou, D. (2023). An overview of recent treatment options for primary sclerosing cholangitis. Annals of Gastroenterology, 36, 589\u2013598.","journal-title":"Annals of Gastroenterology"},{"key":"1226_CR6","first-page":"1267","volume":"11","author":"N Tan","year":"2023","unstructured":"Tan, N., Lubel, J., Kemp, W., Roberts, S., & Majeed, A. (2023). Current therapeutics in primary sclerosing cholangitis. Journal of Clinical and Translational Hepatology, 11, 1267\u20131281.","journal-title":"Journal of Clinical and Translational Hepatology"},{"key":"1226_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","volume":"67","author":"P Fickert","year":"2017","unstructured":"Fickert, P., Hirschfield, G. M., Denk, G., Marschall, H. U., Altorjay, I., F\u00e4rkkil\u00e4, M., Schramm, C., Spengler, U., Chapman, R., Bergquist, A., Schrumpf, E., Nevens, F., Trivedi, P., Reiter, F. P., Tornai, I., Halilbasic, E., Greinwald, R., Pr\u00f6ls, M., Manns, M. P., & Trauner, M. (2017). norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis. Journal of Hepatology, 67, 549\u2013558.","journal-title":"Journal of Hepatology"},{"key":"1226_CR8","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","volume":"73","author":"KV Kowdley","year":"2020","unstructured":"Kowdley, K. V., Vuppalanchi, R., Levy, C., Floreani, A., Andreone, P., LaRusso, N. F., Shrestha, R., Trotter, J., Goldberg, D., Rushbrook, S., Hirschfield, G. M., Schiano, T., Jin, Y., Pencek, R., MacConell, L., Shapiro, D., & Bowlus, C. L. (2020). A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis. Journal of Hepatology, 73, 94\u2013101.","journal-title":"Journal of Hepatology"},{"key":"1226_CR9","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1016\/j.bbadis.2017.06.027","volume":"1864","author":"V Mariotti","year":"2018","unstructured":"Mariotti, V., Strazzabosco, M., Fabris, L., & Calvisi, D. F. (2018). Animal models of biliary injury and altered bile acid metabolism. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1864, 1254\u20131261.","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"1226_CR10","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-9420-5_16","volume":"1981","author":"E Pose","year":"2019","unstructured":"Pose, E., Sancho-Bru, P. & Coll, M. (2019). 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet: a rodent model in cholestasis research. Methods in Molecular Biology, 1981, 249\u2013257.","journal-title":"Methods in Molecular Biology"},{"key":"1226_CR11","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1002\/ptr.7086","volume":"35","author":"M Wen","year":"2021","unstructured":"Wen, M., Liu, Y., Chen, R., He, P., Wu, F., Li, R., & Lin, Y. (2021). Geniposide suppresses liver injury in a mouse model of DDC\u2010induced sclerosing cholangitis. Phytotherapy Research, 35, 3799\u20133811.","journal-title":"Phytotherapy Research"},{"key":"1226_CR12","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jep.2017.07.031","volume":"209","author":"L Xu","year":"2017","unstructured":"Xu, L., Sheng, T., Liu, X., Zhang, T., Wang, Z., & Han, H. (2017). Analyzing the hepatoprotective effect of the Swertia cincta Burkillextract against ANIT-induced cholestasis in rats by modulating the expression of transporters and metabolic enzymes. Journal of Ethnopharmacology, 209, 91\u201399.","journal-title":"Journal of Ethnopharmacology"},{"key":"1226_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jep.2011.08.058","volume":"138","author":"Y Guo","year":"2011","unstructured":"Guo, Y., Pope, C., Cheng, X., Zhou, H., & Klaassen, C. D. (2011). Dose\u2013response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice. Journal of Ethnopharmacology, 138, 111\u2013118.","journal-title":"Journal of Ethnopharmacology"},{"key":"1226_CR14","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ptr.2968","volume":"24","author":"S Kulkarni","year":"2010","unstructured":"Kulkarni, S., & Dhir, A. (2010). Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 24, 317\u2013324.","journal-title":"Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives"},{"key":"1226_CR15","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1517\/13543784.2010.517745","volume":"19","author":"PR Vuddanda","year":"2010","unstructured":"Vuddanda, P. R., Chakraborty, S., & Singh, S. (2010). Berberine: a potential phytochemical with multispectrum therapeutic activities. Expert Opinion on Investigational Drugs, 19, 1297\u20131307.","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"1226_CR16","doi-asserted-by":"crossref","unstructured":"Zhang, Q., Xiao, X., Feng, K., Wang, T., Li, W., Yuan, T., Sun, X., Sun, Q., Xiang, H., & Wang, H. (2010) Berberine moderates glucose and lipid metabolism through multipathway mechanism. Evidence-Based Complementary and Alternative Medicine. 2011, 1\u201310.","DOI":"10.1155\/2011\/924851"},{"key":"1226_CR17","doi-asserted-by":"publisher","first-page":"100540","DOI":"10.1016\/j.hermed.2022.100540","volume":"31","author":"N Malkani","year":"2022","unstructured":"Malkani, N., Sohail, M. I., Ijaz, F., Naeem, A., Mumtaz, S., & Saeed, Z. (2022). Berberis aristata reduces vancomycin-induced nephrotoxicity by down-regulation of cell proliferation markers. Journal of Herbal Medicine, 31, 100540.","journal-title":"Journal of Herbal Medicine"},{"key":"1226_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep20848","volume":"6","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z., Li, B., Meng, X., Yao, S., Jin, L., Yang, J., Wang, J., Zhang, H., Zhang, Z., Cai, D., Zhang, Y. & Ning, G. (2016). Berberine prevents progression from hepatic steatosis to steatohepatitis and fibrosis by reducing endoplasmic reticulum stress. Scientific Reports, 6, 20848.","journal-title":"Scientific Reports"},{"key":"1226_CR19","doi-asserted-by":"publisher","first-page":"814871","DOI":"10.3389\/fphar.2022.814871","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu, X., Wang, L., Tan, S., Chen, Z., Wu, B. & Wu, X. (2022). Therapeutic effects of berberine on liver fibrosis are associated With lipid metabolism and intestinal flora. Frontiers in Pharmacology, 13, 814871.","journal-title":"Frontiers in Pharmacology"},{"key":"1226_CR20","doi-asserted-by":"publisher","first-page":"87412","DOI":"10.1007\/s11356-023-28279-1","volume":"30","author":"A Phogat","year":"2023","unstructured":"Phogat, A., Singh, J., Kumar, V. & Malik, V. (2023). Berberine mitigates acetamiprid-induced hepatotoxicity and inflammation via regulating endogenous antioxidants and NF-\u03baB\/TNF-\u03b1 signaling in rats. Environmental Science and Pollution Research International, 30, 87412\u201387423.","journal-title":"Environmental Science and Pollution Research International"},{"key":"1226_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1574886318666230119093541","volume":"19","author":"M Akhzari","year":"2024","unstructured":"Akhzari, M., Jalili, S., Rashno, S., Akmali, M., Foruozandeh, H. & Barazesh, M. (2024). Evaluation of the antioxidant effects of berberine against sodium nitriteinduced oxidative injury in the rat liver. Current Drug Safety, 19, 51\u201360.","journal-title":"Current Drug Safety"},{"key":"1226_CR22","doi-asserted-by":"publisher","first-page":"106925","DOI":"10.1016\/j.phrs.2023.106925","volume":"196","author":"L Wang","year":"2023","unstructured":"Wang, L., Yan, Y., Wu, L. & Peng, J. (2023). Natural products in non-alcoholic fatty liver disease (NAFLD): novel lead discovery for drug development. Pharmacological Research, 196, 106925.","journal-title":"Pharmacological Research"},{"key":"1226_CR23","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1074\/jbc.M116.757567","volume":"292","author":"P Bu","year":"2017","unstructured":"Bu, P., Le, Y., Zhang, Y., Zhang, Y. & Cheng, X. (2017). Berberine-induced inactivation of signal transducer and activator of transcription 5 signaling promotes male-specific expression of a bile acid uptake transporter. Journal of Biological Chemistry, 292, 4602\u20134613.","journal-title":"Journal of Biological Chemistry"},{"key":"1226_CR24","doi-asserted-by":"publisher","first-page":"14875","DOI":"10.1002\/jcb.28749","volume":"120","author":"H Sadeghi","year":"2019","unstructured":"Sadeghi, H., Azarmehr, N., Razmkhah, F., Sadeghi, H., Danaei, N., Omidifar, N., Vakilpour, H., Pourghadamyari, H., & Doustimotlagh, A. H. (2019). The hydroalcoholic extract of watercress attenuates protein oxidation, oxidative stress, and liver damage after bile duct ligation in rats. Journal of Cellular Biochemistry, 120, 14875\u201314884.","journal-title":"Journal of Cellular Biochemistry"},{"key":"1226_CR25","doi-asserted-by":"publisher","first-page":"208","DOI":"10.14715\/cmb\/2022.68.7.34","volume":"68","author":"I Sohail","year":"2022","unstructured":"Sohail, I., Malkani, N., Tahir, N., Khalil, A., Attar, R., & Mumtaz, S. (2022). Silymarin protects the liver from \u03b1-naphthylisothiocyanate-induced cholestasis by modulating the expression of genes involved in bile acid homeostasis: anti-cholestatic effect of silymarin. Cellular and Molecular Biology, 68, 208\u2013212.","journal-title":"Cellular and Molecular Biology"},{"key":"1226_CR26","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1007\/s11033-020-05635-9","volume":"47","author":"N Malkani","year":"2020","unstructured":"Malkani, N., Naeem, A., Ijaz, F., Mumtaz, S., Ashraf, S. & Sohail, M. I. (2020). Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis. Molecular Biology Reports, 47, 5451\u20135459.","journal-title":"Molecular Biology Reports"},{"key":"1226_CR27","doi-asserted-by":"publisher","first-page":"97137","DOI":"10.18632\/oncotarget.21385","volume":"8","author":"YF Li","year":"2017","unstructured":"Li, Y. F., Wu, J. S., Li, Y. Y., Dai, Y., Zheng, M., Zeng, J. K., Wang, G. F., Wang, T. M., Li, W. K., Zhang, X. Y., Gu, M., Huang, C., Yang, L., Wang, Z. T., & Ma, Y. M. (2017). Chicken bile powder protects against \u03b1-naphthylisothiocyanate-induced cholestatic liver injury in mice. Oncotarget, 8, 97137\u201397152.","journal-title":"Oncotarget"},{"key":"1226_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O., & Olson, A. J. (2010). AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31, 455\u2013461.","journal-title":"Journal of Computational Chemistry"},{"key":"1226_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28, 235\u2013242.","journal-title":"Nucleic Acids Research"},{"key":"1226_CR30","unstructured":"Biovia, D. S. (2021) BIOVIA Discovery Studio Academic Research Suite. San Diego: Dassault Syst\u00e8mes."},{"key":"1226_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/bib\/2.2.195","volume":"2","author":"W Kaplan","year":"2001","unstructured":"Kaplan, W., & Littlejohn, T. G. (2001). Swiss-PDB viewer (deep view). Briefings in Bioinformatics, 2, 195\u2013197.","journal-title":"Briefings in Bioinformatics"},{"key":"1226_CR32","doi-asserted-by":"publisher","first-page":"8.14. 11","DOI":"10.1002\/0471250953.bi0814s24","volume":"24","author":"GM Morris","year":"2008","unstructured":"Morris, G. M., Huey, R., & Olson, A. J. (2008). Using autodock for ligand\u2010receptor docking. Current Protocols In Bioinformatics, 24, 8.14. 11\u201318.14. 40.","journal-title":"Current Protocols In Bioinformatics"},{"key":"1226_CR33","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2019","unstructured":"Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., & Yu, B. (2019). PubChem 2019 update: improved access to chemical data. Nucleic Acids Research, 47, D1102\u2013D1109.","journal-title":"Nucleic Acids Research"},{"key":"1226_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-3-1","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011). Open babel: an open chemical toolbox. Journal of Cheminformatics, 3, 1\u201314.","journal-title":"Journal of Cheminformatics"},{"key":"1226_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.molstruc.2019.04.007","volume":"1188","author":"\u00c1 J\u00e1sz","year":"2019","unstructured":"J\u00e1sz, \u00c1., R\u00e1k, \u00c1., Ladj\u00e1nszki, I., & Cserey, G. (2019). Optimized GPU implementation of Merck molecular force field and universal force field. Journal of Molecular Structure, 1188, 227\u2013233.","journal-title":"Journal of Molecular Structure"},{"key":"1226_CR36","doi-asserted-by":"publisher","first-page":"W271","DOI":"10.1093\/nar\/gku339","volume":"42","author":"JR L\u00f3pez-Blanco","year":"2014","unstructured":"L\u00f3pez-Blanco, J. R., Aliaga, J. I., Quintana-Ort\u00ed, E. S., & Chac\u00f3n, P. (2014). iMODS: internal coordinates normal mode analysis server. Nucleic Acids Research, 42, W271\u2013W276.","journal-title":"Nucleic Acids Research"},{"key":"1226_CR37","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1039\/D0FO02910F","volume":"12","author":"S Zheng","year":"2021","unstructured":"Zheng, S., Cao, P., Yin, Z., Wang, X., Chen, Y., Yu, M., Xu, B., Liao, C., Duan, Y., & Zhang, S. (2021). Apigenin protects mice against 3, 5-diethoxycarbonyl-1, 4-dihydrocollidine-induced cholestasis. Food & Function, 12, 2323\u20132334.","journal-title":"Food & Function"},{"key":"1226_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jhep.2016.08.017","volume":"66","author":"CD Fuchs","year":"2017","unstructured":"Fuchs, C. D., Paumgartner, G., Wahlstr\u00f6m, A., Schwabl, P., Reiberger, T., Leditznig, N., Stojakovic, T., Rohr-Udilova, N., Chiba, P., Marschall, H. U., & Trauner, M. (2017). Metabolic preconditioning protects BSEP\/ABCB11(-\/-) mice against cholestatic liver injury. Journal of Hepatology, 66, 95\u2013101.","journal-title":"Journal of Hepatology"},{"key":"1226_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/187153008784534330","volume":"8","author":"J Yin","year":"2008","unstructured":"Yin, J., Zhang, H. & Ye, J. (2008). Traditional Chinese medicine in treatment of metabolic syndrome. Endocrine, Metabolic & Immune Disorders - Drug Targets, 8, 99\u2013111.","journal-title":"Endocrine, Metabolic & Immune Disorders - Drug Targets"},{"key":"1226_CR40","unstructured":"Bashir, S., Hameed, H., Irshad, N., Ashraf, A., Faizan, M., Halim, S. F., Asjad, H., Batool, A., & Sohail, I. (2023). Hepatoprotective Effect of Berberis Lycium in \u0391lpha-Naphthylisothiocyanate Induced Cholestatic Mouse Models. Journal of Bioresource Management, 10, 88\u201394."},{"key":"1226_CR41","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1002\/ptr.7181","volume":"35","author":"S Bansod","year":"2021","unstructured":"Bansod, S., Saifi, M. A. & Godugu, C. (2021). Molecular updates on berberine in liver diseases: Bench to bedside. Phytotherapy Research, 35, 5459\u20135476.","journal-title":"Phytotherapy Research"},{"key":"1226_CR42","doi-asserted-by":"publisher","first-page":"3593951","DOI":"10.1155\/2016\/3593951","volume":"2016","author":"X Wei","year":"2016","unstructured":"Wei, X., Wang, C., Hao, S., Song, H. & & Yang, L. (2016). The therapeutic effect of berberine in the treatment of nonalcoholic fatty liver disease: a meta-analysis. Evidence-Based Complementary and Alternative Medicine, 2016, 3593951.","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"1226_CR43","doi-asserted-by":"publisher","first-page":"152948","DOI":"10.1016\/j.phymed.2019.152948","volume":"62","author":"WK Li","year":"2019","unstructured":"Li, W.K., Wang, G.F., Wang, T.M., Li, Y.Y., Li, Y.F., Lu, X.Y., Wang, Y.H., Zhang, H., Liu, P., & Wu, J.S. (2019). Protective effect of herbal medicine Huangqi decoction against chronic cholestatic liver injury by inhibiting bile acid-stimulated inflammation in DDC-induced mice. Phytomedicine, 62, 152948.","journal-title":"Phytomedicine"},{"key":"1226_CR44","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/hep.29888","volume":"68","author":"D Slijepcevic","year":"2018","unstructured":"Slijepcevic, D., Roscam Abbing, R. L. P., Fuchs, C. D., Haazen, L. C. M., Beuers, U., Trauner, M., Oude Elferink, R. P. J., & van de Graaf, S. F. J. (2018). Na(+) -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice. Hepatology, 68, 1057\u20131069.","journal-title":"Hepatology"},{"key":"1226_CR45","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1515\/cclm-2013-0096","volume":"51","author":"A Carobene","year":"2013","unstructured":"Carobene, A., Braga, F., Roraas, T., Sandberg, S., & Bartlett, W. A. (2013). A systematic review of data on biological variation for alanine aminotransferase, aspartate aminotransferase and \u03b3-glutamyl transferase. Clinical Chemistry and Laboratory Medicine (CCLM), 51, 1997\u20132007.","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"key":"1226_CR46","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","volume":"71","author":"M Trauner","year":"2022","unstructured":"Trauner, M., & Fuchs, C. D. (2022). Novel therapeutic targets for cholestatic and fatty liver disease. Gut, 71, 194\u2013209.","journal-title":"Gut"},{"key":"1226_CR47","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s10989-020-10157-w","volume":"27","author":"P Ghosh","year":"2021","unstructured":"Ghosh, P., Bhakta, S., Bhattacharya, M., Sharma, A. R., Sharma, G., Lee, S.S., & Chakraborty, C. (2021). A novel multi-epitopic peptide vaccine candidate against Helicobacter pylori: in-silico identification, design, cloning and validation through molecular dynamics. International Journal of Peptide Research and Therapeutics, 27, 1149\u20131166.","journal-title":"International Journal of Peptide Research and Therapeutics"},{"key":"1226_CR48","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1016\/j.febslet.2006.08.037","volume":"580","author":"N Floquet","year":"2006","unstructured":"Floquet, N., Marechal, J.D., Badet-Denisot, M.A., Robert, C. H., Dauchez, M., & Perahia, D. (2006). Normal mode analysis as a prerequisite for drug design: application to matrix metalloproteinases inhibitors. FEBS Letters, 580, 5130\u20135136.","journal-title":"FEBS Letters"},{"key":"1226_CR49","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.bpj.2009.07.019","volume":"97","author":"H Kamberaj","year":"2009","unstructured":"Kamberaj, H., & van der Vaart, A. (2009). Extracting the causality of correlated motions from molecular dynamics simulations. Biophysical Journal, 97, 1747\u20131755.","journal-title":"Biophysical Journal"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01226-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01226-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T06:15:46Z","timestamp":1724480146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01226-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1226"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01226-8","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]},"assertion":[{"value":"2 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed following the guidelines of the institutional bioethical committee (GCU-IIB-2416).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}